Healthcare biotech; currently trading ~47% above its initial offering.
An AI hyperscaler providing cloud infrastructure for GenAI models. It is considered one of the top performers of 2025/2026 due to the surging demand for AI compute. recent ipos to buy
A payments processing leader with a private valuation near $159 billion. To help you decide which IPOs fit your portfolio, Healthcare biotech; currently trading ~47% above its initial
The "Buy Now, Pay Later" giant went public in late 2025. Several major institutions like Deutsche Bank and Bank of America have since issued "Buy" ratings with price targets ranging from $48 to $51. A payments processing leader with a private valuation
This index tracks the performance of recent US listings. After a period of volatility in 2025, it has shown a recovery trend in early 2026. FTSE Renaissance US Ipo Index (IPOS) 7.81% since Jan 3, 2025 As of Apr 27, 23:09 GMT+3 • Disclaimer Apr 27, 2026 Open845.16 52-wk high845.24 High845.24 Prev close845.16 52-wk low837.69 📅 Notable April 2026 Debuts